Pinki Bhatt, MD

Dr. Pinki J. Bhatt is an Associate Professor of Medicine and the Section Chief of Transplant and Oncology Infectious Diseases at Rutgers Robert Wood Johnson Medical School. She completed her Internal Medicine residency at the University of Texas Medical Branch – Galveston, followed by Infectious Diseases fellowship training with a dedicated Transplant ID track at the Icahn School of Medicine at Mount Sinai Hospital in New York. She is board-certified in Internal Medicine and Infectious Diseases.

Dr. Bhatt joined the Rutgers faculty in 2017 and currently serves as the Associate Program Director for the Infectious Diseases Fellowship. She also directs the Transplant Infectious Diseases Track for the ID fellowship and co-leads the Immunocompromised Host inpatient service. In addition, she holds an adjunct faculty appointment at the Rutgers Ernest Mario School of Pharmacy. She actively participates in several hospital and transplant committees, including the kidney, pancreas, and heart transplant listing committees, oncology and transplant quality committees, and the Institutional Review Board.

Her clinical expertise includes the care of solid organ transplant recipients (kidney, pancreas, and heart), hematopoietic stem cell transplant recipients, patients with hematologic malignancies, and individuals supported by left ventricular assist devices. She has a particular focus on complex infections in immunocompromised hosts and serves as a resource for oncology and transplant teams across the health system.

Dr. Bhatt is an active member of the Infectious Diseases Society of America, including the Immunocompromised Host Community of Practice, International Society of Heart and Lung Transplantation and the American Society of Transplantation Infectious Diseases Community of Practice. She frequently lectures regionally and nationally on transplant and oncology infectious diseases.

Her research interests include latent tuberculosis infection in solid organ transplant candidates and recipients and antifungal prophylaxis strategies. She also serves as a clinical trials principal investigator and collaborates across multiple institutions on transplant ID research initiatives.